Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Pediatr Nephrol. 2018 Oct 5;34(10):1683–1695. doi: 10.1007/s00467-018-4104-2

Figure 1. HDL changes in chronic kidney disease (CKD).

Figure 1.

HDL in CKD becomes enriched in SAA, SDMA, apoCIII and apoAIV, while decreasing the content of apoAI and PON1. CKD degrades several potentially beneficial functionalities of HDL.

HDL, high density lipoprotein; TG, triglyceride; PON1, paraoxonase 1; apoAI, apolipoprotein AI; apoAII, apolipoprotein apoAII; apoAIV, apolipoprotein IV; apoCIII, apolipoprotein apoCIII; SAA, serum amyloid A; SDMA, symmetric dimethylarginine.